HK1075616A1 - Pharmaceutical formulation comprising melatonin - Google Patents

Pharmaceutical formulation comprising melatonin

Info

Publication number: HK1075616A1
Authority: HK; Hong Kong
Prior art keywords: melatonin; pharmaceutical formulation; barbiturate; effected; short
Prior art date: 2002-04-28

Application number

HK05107777A

Other languages

English (en)

Inventor

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-28

Filing date

2005-09-05

Publication date

2005-12-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29227410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1075616(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-09-05 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

2005-12-23 Publication of HK1075616A1 publication Critical patent/HK1075616A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Indole Compounds (AREA)

HK05107777A 2002-04-28 2005-09-05 Pharmaceutical formulation comprising melatonin HK1075616A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL149377A IL149377A (en)	2002-04-28	2002-04-28	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
PCT/IL2003/000240 WO2003086352A1 (en)	2002-04-08	2003-03-20	Pharmaceutical formulation comprising melatonin

Publications (1)

Publication Number	Publication Date
HK1075616A1 true HK1075616A1 (en)	2005-12-23

Family

ID=29227410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK05107777A HK1075616A1 (en)	2002-04-28	2005-09-05	Pharmaceutical formulation comprising melatonin

Country Status (30)

Country	Link
US (1)	US20050175692A1 (uk)
EP (1)	EP1494650B1 (uk)
JP (1)	JP2005527583A (uk)
KR (1)	KR101000624B1 (uk)
CN (1)	CN100386070C (uk)
AR (1)	AR039232A1 (uk)
AT (1)	ATE507831T1 (uk)
AU (1)	AU2003227304B2 (uk)
BR (1)	BR0308762A (uk)
CA (1)	CA2477516C (uk)
DE (1)	DE60336999D1 (uk)
DK (1)	DK1494650T3 (uk)
EA (1)	EA007954B1 (uk)
ES (1)	ES2366116T3 (uk)
GT (1)	GT200300064A (uk)
HK (1)	HK1075616A1 (uk)
HN (1)	HN2003000115A (uk)
IL (1)	IL149377A (uk)
IS (1)	IS2858B (uk)
MX (1)	MXPA04009893A (uk)
NO (1)	NO332525B1 (uk)
NZ (1)	NZ536298A (uk)
PE (1)	PE20040161A1 (uk)
PL (1)	PL209922B1 (uk)
PT (1)	PT1494650E (uk)
TW (1)	TW200305404A (uk)
UA (1)	UA86924C2 (uk)
UY (1)	UY27753A1 (uk)
WO (1)	WO2003086352A1 (uk)
ZA (1)	ZA200407563B (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2551637A1 (en) *	2003-12-24	2005-07-14	Sepracor Inc.	Melatonin combination therapy for improving sleep quality
TW200626137A (en) *	2004-12-13	2006-08-01	Takeda Pharmaceuticals Co	Preventive or therapeutic agent for sleep disorder
US20060198872A1 (en) *	2005-03-07	2006-09-07	Chioma Ikonte	Plant based dietary supplement for improving the duration and quality of sleep
KR20070070307A (ko) *	2005-08-24	2007-07-04	에스에스 세야쿠 가부시키 가이샤	수면 개선 의약 조성물
CN1299680C (zh) *	2005-08-29	2007-02-14	陈彦方	一种治疗失眠的黑白制剂
AR056076A1 (es) *	2005-09-20	2007-09-19	Takeda Pharmaceutical	Agente profilactico o terapeutico para el desorden de sueno
CN102018681A (zh) *	2010-12-10	2011-04-20	荣港生技医药科技（北京）有限公司	一种美乐托宁缓释剂、其制备方法及其应用
US9532952B2 (en) *	2011-01-28	2017-01-03	Physician's Seal, LLC	Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en)	2011-01-28	2012-08-02	Zx Pharma, Llc	Controlled-release melatonin composition and related methods
EP2570126B1 (en)	2011-09-16	2014-03-26	Darius Rassoulian	Use of melatonin for treating acute alcohol intoxication
WO2018078429A1 (en)	2016-10-31	2018-05-03	Neurim Pharmaceuticals Ltd.	Melatonin mini-tablets and method of manufacturing the same
US10849856B2 (en)	2016-10-31	2020-12-01	Neurim Pharmaceuticals Ltd.	Melatonin mini-tablets and method of manufacturing the same
CN109364031A (zh) *	2018-10-07	2019-02-22	威海贯标信息科技有限公司	一种盐酸曲唑酮片剂组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4600723A (en) *	1983-05-18	1986-07-15	Monash University	Method for minimizing disturbances in circadian rhythms of bodily performance and function
US5707652A (en) *	1990-12-04	1998-01-13	State Of Oregon	Methods of treating circadian rhythm phase disorders
IT1251544B (it) *	1991-05-13	1995-05-17	Gabriele Biella	Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
FR2718020B1 (fr) *	1994-04-01	1996-05-31	Biotec Centre Sa	Composition galénique mucoadhésive hétérofonctionnelle.
SI9620022A (sl) *	1995-02-01	1998-10-31	Neurim Pharmaceuticals (1991) Ltd.	Uporaba melatonina za odvajanje od zasvojenosti
CN100441574C (zh) *	1996-03-08	2008-12-10	武田药品工业株式会社	三环化合物及其制备和用途
AU2583397A (en) *	1996-04-10	1997-10-29	Chronorx, Llc	Unit dosage forms, containing magnesium, vitamin c, vitamin e, folate and selenium, for treatment of vasoconstriction and related conditions
CA2260269A1 (en) *	1996-07-17	1998-01-22	Merck & Co., Inc.	Alteration of circadian rhythmicity with a tachykinin antagonist
US6348485B1 (en) *	1998-06-09	2002-02-19	Takeda Chemical Industries, Ltd.	Method for treating or preventing sleep disorders
CN1131030C (zh) *	1999-03-18	2003-12-17	胡秀云	一种由褪黑素和安定制成的调节睡眠的组合物
US6274635B1 (en)	1999-03-22	2001-08-14	Immugen Pharmaceuticals Inc.	Alkylated resorcinol derivatives for the treatment of immune diseases
IL144900A (en) *	2001-08-14	2013-12-31	Neurim Pharma 1991	Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs

2002
- 2002-04-28 IL IL149377A patent/IL149377A/en active IP Right Grant
2003
- 2003-03-17 GT GT200300064A patent/GT200300064A/es unknown
- 2003-03-20 CA CA2477516A patent/CA2477516C/en not_active Expired - Lifetime
- 2003-03-20 PT PT03746393T patent/PT1494650E/pt unknown
- 2003-03-20 ES ES03746393T patent/ES2366116T3/es not_active Expired - Lifetime
- 2003-03-20 BR BR0308762-0A patent/BR0308762A/pt not_active Application Discontinuation
- 2003-03-20 MX MXPA04009893A patent/MXPA04009893A/es active IP Right Grant
- 2003-03-20 AU AU2003227304A patent/AU2003227304B2/en not_active Expired
- 2003-03-20 AT AT03746393T patent/ATE507831T1/de active
- 2003-03-20 EA EA200401331A patent/EA007954B1/ru not_active IP Right Cessation
- 2003-03-20 US US10/510,625 patent/US20050175692A1/en not_active Abandoned
- 2003-03-20 NZ NZ536298A patent/NZ536298A/en not_active IP Right Cessation
- 2003-03-20 DE DE60336999T patent/DE60336999D1/de not_active Expired - Lifetime
- 2003-03-20 JP JP2003583375A patent/JP2005527583A/ja active Pending
- 2003-03-20 EP EP03746393A patent/EP1494650B1/en not_active Expired - Lifetime
- 2003-03-20 KR KR1020047015934A patent/KR101000624B1/ko active IP Right Grant
- 2003-03-20 PE PE2003000278A patent/PE20040161A1/es not_active Application Discontinuation
- 2003-03-20 UA UA20041008558A patent/UA86924C2/uk unknown
- 2003-03-20 WO PCT/IL2003/000240 patent/WO2003086352A1/en active Application Filing
- 2003-03-20 PL PL372867A patent/PL209922B1/pl unknown
- 2003-03-20 DK DK03746393.2T patent/DK1494650T3/da active
- 2003-03-20 CN CNB038075644A patent/CN100386070C/zh not_active Expired - Lifetime
- 2003-04-01 TW TW092107377A patent/TW200305404A/zh unknown
- 2003-04-02 AR ARP030101156A patent/AR039232A1/es not_active Application Discontinuation
- 2003-04-07 UY UY27753A patent/UY27753A1/es not_active Application Discontinuation
- 2003-04-07 HN HN2003000115A patent/HN2003000115A/es unknown
2004
- 2004-08-27 NO NO20043576A patent/NO332525B1/no not_active IP Right Cessation
- 2004-09-21 ZA ZA2004/07563A patent/ZA200407563B/en unknown
- 2004-10-07 IS IS7492A patent/IS2858B/is unknown
2005
- 2005-09-05 HK HK05107777A patent/HK1075616A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2366116T3 (es)	2011-10-17
BR0308762A (pt)	2005-01-11
GT200300064A (es)	2003-11-26
IL149377A (en)	2012-10-31
CN100386070C (zh)	2008-05-07
AU2003227304A1 (en)	2003-10-27
NO332525B1 (no)	2012-10-08
AU2003227304B2 (en)	2007-12-06
IL149377A0 (en)	2009-02-11
UY27753A1 (es)	2003-05-30
IS2858B (is)	2013-12-15
ATE507831T1 (de)	2011-05-15
MXPA04009893A (es)	2005-06-17
PL209922B1 (pl)	2011-11-30
JP2005527583A (ja)	2005-09-15
EA200401331A1 (ru)	2005-04-28
CA2477516C (en)	2012-12-11
DE60336999D1 (de)	2011-06-16
IS7492A (is)	2004-10-07
UA86924C2 (uk)	2009-06-10
KR101000624B1 (ko)	2010-12-10
PL372867A1 (en)	2005-08-08
ZA200407563B (en)	2005-11-30
WO2003086352A1 (en)	2003-10-23
EP1494650A4 (en)	2006-07-12
NZ536298A (en)	2008-09-26
EA007954B1 (ru)	2007-02-27
EP1494650B1 (en)	2011-05-04
HN2003000115A (es)	2004-04-20
DK1494650T3 (da)	2011-08-08
PE20040161A1 (es)	2004-03-22
NO20043576L (no)	2004-12-22
PT1494650E (pt)	2011-08-18
TW200305404A (en)	2003-11-01
AU2003227304A2 (en)	2005-04-14
US20050175692A1 (en)	2005-08-11
AR039232A1 (es)	2005-02-09
EP1494650A1 (en)	2005-01-12
CA2477516A1 (en)	2003-10-23
KR20040101406A (ko)	2004-12-02
CN1646098A (zh)	2005-07-27

Publication	Publication Date	Title
HK1075616A1 (en)	2005-12-23	Pharmaceutical formulation comprising melatonin
SG145701A1 (en)	2008-09-29	Piperazine derivatives and their use as therapeutic agents
CY1109229T1 (el)	2013-09-04	Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
BRPI0415639A (pt)	2006-12-12	formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia
SG145695A1 (en)	2008-09-29	Pyridyl derivatives and their use as therapeutic agents
SG145700A1 (en)	2008-09-29	Pyridyl derivatives and their use as therapeutic agents
NO20062504L (no)	2006-07-21	Sammensetninger og doseringsformer for forbedret absorpsjon
MXPA05008406A (es)	2006-02-17	Compuestos de amida tri(ciclo)-sustituida.
TW200626526A (en)	2006-08-01	Pharmaceutical compositions for the treatment of neoplasms
MY138059A (en)	2009-04-30	Use of ikb-kinase inhibitors in pain therapy
PL1654253T3 (pl)	2007-05-31	Podstawione pochodne 3-pirolidynoindolu
DE60327103D1 (de)	2009-05-20	Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
SG146442A1 (en)	2008-10-30	Sulphonamide derivatives, their preparation and use as medicaments
UA88300C2 (uk)	2009-10-12	Гідрогелеві композиції, що містять інтерферон
ATE301999T1 (de)	2005-09-15	Racecadotril enthaltende trockene pulverformulierung
CL2004000877A1 (es)	2005-01-07	Combinacion farmaceutica que comprende 8a) melatonina y agonistas de la melatonina, y nicotina y agonistas receptores de nicotina; kit farmaceutico, y; uso en el tratamiento de insomnio, dificultades cognitivas y dificultades de memoria; kit farmaceu
HUP0401484A3 (en)	2007-03-28	Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine and pharmaceutical compositions containing the combination
ITRM20030555A1 (it)	2004-06-10	Prodotto di igiene buccodentale per uso umano e veterinario a base di melatonina come principio attivo.
ITRM20020119A0 (it)	2002-03-05	Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
AU2003281257A1 (en)	2004-01-23	A novel use of rapamycin and structural analogues thereof
AU2003250999A1 (en)	2004-02-23	Cosmetic use of lignans
PL1663101T3 (pl)	2007-06-29	Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
AU2003240446A1 (en)	2003-10-13	Use of mob-5 in pain
NO20071096L (no)	2007-04-26	Diarylmetylpiperazinderivater, fremstillinger derav og anvendelser derav
BRPI0417098A (pt)	2007-03-13	uso da osteopontina em formulações dentais

Legal Events

Date	Code	Title	Description
2023-03-31	PE	Patent expired	Effective date: 20230316